Symptoms of Vernal Keratoconjunccularitis (VKC) are intense itching, redness, and watering of the eyes. Patients may experience photophobia and feel as if something is stuck in their eye. VKC is seasonal and affects both eyes, but up to 23% of patients have a recurring chronic form of the disease. Besides the typical symptoms, patients may also have conjunctival hyperemia and thick mucous discharge.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4657
Treatment for VKC is centered on preventing or alleviating the symptoms. In milder forms of the condition, patients may experience occasional episodes of inflammation of the limbus. In more severe cases, patients may develop papillae on the tarsal side. Moreover, patients may also have inflammatory keratitis and have an elevated white blood cell count. Fortunately, most patients recover without any lasting vision damage.
The global vernal keratoconjunctivitis market is expected to record a CAGR of 3.6% during 2021-2028 and was estimated to be valued at US$ 346.9 million in 2021.
Global Vernal Keratoconjunctivitis Market: Drivers
Approval and launch of new products is expected to propel growth of the global vernal keratoconjunctivitis market over the forecast period. For example, the U.S. Food and Drug Administration approved, in June 2021, Santen Pharmaceutical Co., Ltd.’s verkazia (Cyclosporine Ophthalmic Emulsion, 0.1%) for the treatment of vernal keratoconjunctivitis.
Moreover, high prevalence of vernal keratoconjunctivitis is also expected to propel growth of the global vernal keratoconjunctivitis market over the forecast period. For instance, in August 2021, Western Europe incidences were 3.2 in 10,000, whereas in Italy, a country with a Mediterranean climate, a higher prevalence ranging from 2.4 to 27.8 in 10,000 were observed.
Global Vernal Keratoconjunctivitis Market: Restraints
No precise diagnostic criteria for vernal keratoconjunctivitis means that several mild or unusual instances may be undetected. This in turn is expected to limit growth of the global vernal keratoconjunctivitis market.
Global Vernal Keratoconjunctivitis Market: Competitive Landscape
Major players operating in the global vernal keratoconjunctivitis market include, Akari Therapeutics, Allakos, iCo Therapeutics, Novartis Pharmaceuticals, Santen, and Senju Pharmaceutical.
Global Vernal Keratoconjunctivitis Market: Segmentation
By Drug Type:
- Mast Cell Stabilizers
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Topical Corticosteroids
By Dosage Form:
By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Get PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/4657
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Vernal Keratoconjunctivitis Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Vernal Keratoconjunctivitis Industry Impact
Chapter 2 Global Vernal Keratoconjunctivitis Competition by Types, Applications, and Top Regions and Countries
2.1 Global Vernal Keratoconjunctivitis (Volume and Value) by Type
2.3 Global Vernal Keratoconjunctivitis (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Vernal Keratoconjunctivitis Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Vernal Keratoconjunctivitis Market Analysis
Chapter 6 East Asia Vernal Keratoconjunctivitis Market Analysis
Chapter 7 Europe Vernal Keratoconjunctivitis Market Analysis
Chapter 8 South Asia Vernal Keratoconjunctivitis Market Analysis
Chapter 9 Southeast Asia Vernal Keratoconjunctivitis Market Analysis
Chapter 10 Middle East Vernal Keratoconjunctivitis Market Analysis
Chapter 11 Africa Vernal Keratoconjunctivitis Market Analysis
Chapter 12 Oceania Vernal Keratoconjunctivitis Market Analysis
Chapter 13 South America Vernal Keratoconjunctivitis Market Analysis
Chapter 14 Company Profiles and Key Figures in Vernal Keratoconjunctivitis Business
Chapter 15 Global Vernal Keratoconjunctivitis Market Forecast (2022-2028)
Chapter 16 Conclusions
Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/4657
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027